- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: advanced solid tumor malignancies
Total 49299 results
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Malignancies | Hematologic MalignanciesUnited States
-
Incyte CorporationTerminatedSolid Tumors and Hematologic MalignancyUnited States
-
AstraZenecaTerminatedCancer | Advanced Solid MalignanciesUnited States, Italy, United Kingdom, France, Germany, Spain, Netherlands
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced MalignanciesUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Mirati Therapeutics Inc.CompletedAdvanced CancerUnited States, Korea, Republic of, Canada
-
University of Colorado, DenverSpringWorks Therapeutics, Inc.No longer availableNeoplasm | Desmoid TumorUnited States
-
PlexxikonTerminatedAcute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Myelodysplastic Syndrome | Solid TumorsUnited States
-
Genentech, Inc.CompletedHematologic Malignancies | TumorsSpain, France, United States, United Kingdom
-
National Cancer Institute (NCI)CompletedRenal Cell Carcinoma | Breast Cancer | Lung Cancer | Non-Hodgkin Lymphoma | Colon CancerUnited States
-
Hutchison Medipharma LimitedTerminated
-
M.D. Anderson Cancer CenterVioQuest PharmaceuticalsCompletedAdvanced Cancer | Solid TumorsUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
Washington University School of MedicineCompletedSolid Tumor | Solid MalignancyUnited States
-
National Cancer Institute (NCI)Completed
-
EMD SeronoCompletedSolid TumorUnited States
-
Novartis PharmaceuticalsNantCell, Inc.TerminatedPIK3CA Mutated Advanced Solid Tumors | PIK3CA Amplified Advanced Solid TumorsSpain, Belgium, United States, Canada
-
Immune System Key LtdCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustAstraZenecaCompleted
-
CelgeneWithdrawnSolid TumorUnited States
-
Emory UniversityNovartis PharmaceuticalsCompletedLung Cancer | Solid TumorsUnited States
-
Incyte CorporationTerminatedBreast Cancer | Pancreatic Cancer | Hodgkin's Lymphoma | Solid Tumor | Metastatic Cancer | Advanced Cancer | NHL (Non-Hodgkin Lymphoma) | UC (Ureter and Urethera)United States
-
Incyte CorporationCompletedSolid Tumors and Hematologic MalignancyUnited States
-
AstraZenecaCompletedCancer | Advanced Solid MalignanciesJapan
-
Hoffmann-La RocheCompletedSolid Tumors, Advanced Solid TumorsUnited States
-
Incyte CorporationNovartis PharmaceuticalsCompletedSolid Tumor | Metastatic Cancer | Advanced CancerUnited States
-
CelgeneCompletedCancer | LymphomasUnited States
-
Genentech, Inc.Terminated
-
AmgenCompletedHepatic Impairment | Solid Tumors | Hematologic MalignanciesUnited Kingdom, Netherlands, United States, France
-
British Columbia Cancer AgencyBC Cancer FoundationCompletedGastrointestinal Stromal Tumors | Colorectal Cancer Metastatic | Advanced Melanoma | Advanced Non-Small Cell Lung Carcinoma | Patients With Diagnosed Malignancies Being Considered for Clinical TrialsCanada
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); PfizerCompletedNeoplasms, AdvancedUnited States
-
Emory UniversityAmgenCompletedNeoplasms | MalignanciesUnited States
-
R-PharmCompletedNeoplasms | Advanced Solid TumorsUnited States
-
Ningbo Cancer HospitalUnknownAdvanced Cancer | Solid Tumor, AdultChina
-
Cornerstone PharmaceuticalsCompletedLymphoma | Metastatic Cancer | Advanced Cancer | Solid Tumors | Advanced MalignanciesUnited States, Canada
-
Kinex Pharmaceuticals Inc.Atlantic Research GroupCompleted
-
Celgene CorporationCompletedNeoplasms | Metastases, NeoplasmUnited States
-
Ningbo Cancer HospitalUnknownAdvanced Malignancies | PD-1 Antibody | CAR-T CellsChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Nausea and VomitingUnited States
-
M.D. Anderson Cancer CenterCompletedSolid Tumors | Advanced CancersUnited States
-
AstraZenecaCompletedCancer | Advanced Solid MalignanciesJapan
-
Astellas Pharma IncCompletedSolid Tumor | B-Cell Lymphoma | Advanced Malignancies | Positive for Anaplastic Lymphoma Kinase | Positive for Proto-Oncogene Tyrosine-Protein Kinase ROSUnited States
-
M.D. Anderson Cancer CenterCelgeneCompletedAdvanced CancersUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | Hematologic MalignanciesUnited States
-
AstraZenecaCompletedAdvanced Solid Tumor | Advanced Solid MalignancyJapan
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedBladder Cancer | Ureter Cancer | Renal Pelvis CancerUnited States
-
Debiopharm International SATerminated
-
Georgetown UniversityGlaxoSmithKline; Millennium Pharmaceuticals, Inc.Terminated